Simplex Trading
ARGS

Simplex Trading’s Argos Therapeutics, Inc. ARGS Stock Holding History

Simplex Trading’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3
Closed -$1K – 7439
2016
Q4 		$1K Hold
3
– – ﹤0.01% 5725
2016
Q3 		$1K Buy
3
+2
+200% +$209 ﹤0.01% 5675
2016
Q2 		$1K Buy
+1
New +$134 ﹤0.01% 5683

Other funds holding ARGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Simplex Trading's ARGS Position: Q2 2017 in Review

Simplex Trading sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2017, closing a stake of 650 shares — an estimated $5.53K sold.

Simplex Trading first reported a position in ARGS in Q2 2016 and held it in 4 quarters. The position peaked at $70K in Q2 2016. 34 funds tracked by Wall St. Rank hold ARGS as of Q2 2017.

  • Simplex Trading reported no remaining Argos Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Simplex Trading sold 650 Argos Therapeutics, Inc. shares in Q2 2017, an estimated $5.53K.
  • Simplex Trading first reported a position in Argos Therapeutics, Inc. in Q2 2016 and held it in 4 quarters.
  • Simplex Trading's Argos Therapeutics, Inc. position peaked at $70K in Q2 2016.
  • 34 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2017.

Based on Simplex Trading's 13F filing for Q2 2017, filed 12 Jul 2017.